We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor immunoglobulins in the largest cohort (n=565) studied for this purpose. By combining data on recurrent gene mutations (BIRC3, MYD88, NOTCH1, SF3B1 and TP53) and cytogenetic aberrations, we reveal a subset-biased acquisition of gene mutations. More specifically, the frequency of NOTCH1 mutations was found to be enriched in subsets expressing unmutated immunoglobulin genes, i.e. #1, #6, #8 and #59 (22-34%), often in association with trisomy 12, and was significantly different (P<0.001) to the frequency observed in subset #2 (4%, aggressive disease, variable somatic hypermutation status) and subset #4 (1%, indolent disease, mutated immunoglobulin genes). Interestingly, subsets harboring a high frequency of NOTCH1 mutations were found to carry few (if any) SF3B1 mutations. This starkly contrasts with subsets #2 and #3 where, despite their immunogenetic differences, SF3B1 mutations occurred in 45% and 46% of cases, respectively. In addition, mutations within TP53, whilst enriched in subset #1 (16%), were rare in subsets #2 and #8 (both 2%), despite all being clinically aggressive. All subsets were negative for MYD88 mutations, whereas BIRC3 mutations were infrequent. Collectively, this striking bias and skewed distribution of mutations and cytogenetic aberrations within specific chronic lymphocytic leukemia subsets implies that the mechanisms underlying clinical aggressiveness are not uniform, but rather support the existence of distinct genetic pathways of clonal evolution governed by a particular stereotyped B-cell receptor selecting a certain molecular lesion(s).

1st Department of Propaedeutic Medicine University of Athens Greece

Cancer Sciences Faculty of Medicine University of Southampton UK

Central European Institute of Technology Masaryk University and University Hospital Brno Czech Republic

Department of Haematology Royal Bournemouth Hospital Bournemouth UK

Department of Hematology Rigshospitalet Copenhagen Denmark

Department of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands

Department of Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Uppsala Sweden

Department of Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Uppsala Sweden Institute of Applied Biosciences CERTH Thessaloniki Greece Hematology Department and HCT Unit G Papanicolaou Hospital Thessaloniki Greece

Division of Haematology Department of Translational Medicine Amedeo Avogadro University of Eastern Piedmont Novara Italy

Hematology Department and University Pierre et Marie Curie Hopital Pitie Salpetriere Paris France

Hematology Department Nikea General Hospital Piraeus Greece

Hematopathology Unit and Department of Hematology Hospital Clinic University of Barcelona Institut d'Investigacions Biomèdiques August Pi iSunyer Barcelona Spain

Institute of Applied Biosciences CERTH Thessaloniki Greece

The Feinstein Institute for Medical Research North Shore Long Island Jewish Health System Manhasset New York NY USA

Università Vita Salute San Raffaele Milan Italy Division of Experimental Oncology and Department of Onco Hematology IRCCS San Raffaele Scientific Institute Milan Italy

000      

00000naa a2200000 a 4500

001      

bmc17031726

003      

CZ-PrNML

005      

20171025125424.0

007      

ta

008      

171025s2016 it f 000 0|eng||

009      

AR

024    7_

$a 10.3324/haematol.2016.141812 $2 doi

035    __

$a (PubMed)27198719

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a it

100    1_

$a Sutton, Lesley-Ann $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

245    10

$a Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors / $c LA. Sutton, E. Young, P. Baliakas, A. Hadzidimitriou, T. Moysiadis, K. Plevova, D. Rossi, J. Kminkova, E. Stalika, LB. Pedersen, J. Malcikova, A. Agathangelidis, Z. Davis, L. Mansouri, L. Scarfò, M. Boudjoghra, A. Navarro, AF. Muggen, XJ. Yan, F. Nguyen-Khac, M. Larrayoz, P. Panagiotidis, N. Chiorazzi, CU. Niemann, C. Belessi, E. Campo, JC. Strefford, AW. Langerak, D. Oscier, G. Gaidano, S. Pospisilova, F. Davi, P. Ghia, K. Stamatopoulos, R. Rosenquist, . ,

520    9_

$a We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor immunoglobulins in the largest cohort (n=565) studied for this purpose. By combining data on recurrent gene mutations (BIRC3, MYD88, NOTCH1, SF3B1 and TP53) and cytogenetic aberrations, we reveal a subset-biased acquisition of gene mutations. More specifically, the frequency of NOTCH1 mutations was found to be enriched in subsets expressing unmutated immunoglobulin genes, i.e. #1, #6, #8 and #59 (22-34%), often in association with trisomy 12, and was significantly different (P<0.001) to the frequency observed in subset #2 (4%, aggressive disease, variable somatic hypermutation status) and subset #4 (1%, indolent disease, mutated immunoglobulin genes). Interestingly, subsets harboring a high frequency of NOTCH1 mutations were found to carry few (if any) SF3B1 mutations. This starkly contrasts with subsets #2 and #3 where, despite their immunogenetic differences, SF3B1 mutations occurred in 45% and 46% of cases, respectively. In addition, mutations within TP53, whilst enriched in subset #1 (16%), were rare in subsets #2 and #8 (both 2%), despite all being clinically aggressive. All subsets were negative for MYD88 mutations, whereas BIRC3 mutations were infrequent. Collectively, this striking bias and skewed distribution of mutations and cytogenetic aberrations within specific chronic lymphocytic leukemia subsets implies that the mechanisms underlying clinical aggressiveness are not uniform, but rather support the existence of distinct genetic pathways of clonal evolution governed by a particular stereotyped B-cell receptor selecting a certain molecular lesion(s).

650    12

$a nádorové biomarkery $7 D014408

650    _2

$a hypervariabilní oblasti $x genetika $7 D022801

650    _2

$a cytogenetické vyšetření $7 D020732

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a frekvence genu $7 D005787

650    _2

$a genová přestavba B-lymfocytů $7 D015322

650    _2

$a geny pro imunoglobuliny $7 D005803

650    _2

$a lidé $7 D006801

650    _2

$a těžké řetězce imunoglobulinů $x genetika $7 D007143

650    _2

$a imunoglobuliny - vazebný region $x genetika $7 D007133

650    _2

$a variabilní oblast imunoglobulinu $x genetika $7 D007135

650    _2

$a chronická lymfatická leukemie $x genetika $x metabolismus $x mortalita $7 D015451

650    _2

$a mužské pohlaví $7 D008297

650    12

$a mutace $7 D009154

650    _2

$a jednonukleotidový polymorfismus $7 D020641

650    _2

$a prognóza $7 D011379

650    _2

$a receptory antigenů B-buněk $x genetika $x metabolismus $7 D011947

655    _2

$a časopisecké články $7 D016428

700    1_

$a Young, Emma $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

700    1_

$a Baliakas, Panagiotis $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

700    1_

$a Hadzidimitriou, Anastasia $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.

700    1_

$a Moysiadis, Theodoros $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.

700    1_

$a Plevova, Karla $u Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.

700    1_

$a Rossi, Davide $u Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

700    1_

$a Kminkova, Jana $u Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.

700    1_

$a Stalika, Evangelia $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.

700    1_

$a Pedersen, Lone Bredo $u Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

700    1_

$a Malcikova, Jitka $u Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.

700    1_

$a Agathangelidis, Andreas $u Università Vita-Salute San Raffaele, Milan, Italy Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy. $7 gn_A_00002103

700    1_

$a Davis, Zadie $u Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.

700    1_

$a Mansouri, Larry $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

700    1_

$a Scarfò, Lydia $u Università Vita-Salute San Raffaele, Milan, Italy Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy.

700    1_

$a Boudjoghra, Myriam $u Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.

700    1_

$a Navarro, Alba $u Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.

700    1_

$a Muggen, Alice F $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands.

700    1_

$a Yan, Xiao-Jie $u The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, NY, USA.

700    1_

$a Nguyen-Khac, Florence $u Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.

700    1_

$a Larrayoz, Marta $u Cancer Sciences, Faculty of Medicine, University of Southampton, UK.

700    1_

$a Panagiotidis, Panagiotis $u First Department of Propaedeutic Medicine, University of Athens, Greece.

700    1_

$a Chiorazzi, Nicholas $u The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, NY, USA.

700    1_

$a Niemann, Carsten Utoft $u Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

700    1_

$a Belessi, Chrysoula $u Hematology Department, Nikea General Hospital, Piraeus, Greece.

700    1_

$a Campo, Elias $u Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.

700    1_

$a Strefford, Jonathan C $u Cancer Sciences, Faculty of Medicine, University of Southampton, UK.

700    1_

$a Langerak, Anton W $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands.

700    1_

$a Oscier, David $u Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.

700    1_

$a Gaidano, Gianluca $u Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

700    1_

$a Pospisilova, Sarka $u Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.

700    1_

$a Davi, Frederic $u Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.

700    1_

$a Ghia, Paolo $u Università Vita-Salute San Raffaele, Milan, Italy Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy.

700    1_

$a Stamatopoulos, Kostas $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden Institute of Applied Biosciences, CERTH, Thessaloniki, Greece Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.

700    1_

$a Rosenquist, Richard $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden richard.rosenquist@igp.uu.se.

700    1_

$a ,

773    0_

$w MED00001963 $t Haematologica $x 1592-8721 $g Roč. 101, č. 8 (2016), s. 959-67

856    41

$u https://pubmed.ncbi.nlm.nih.gov/27198719 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20171025 $b ABA008

991    __

$a 20171025125506 $b ABA008

999    __

$a ok $b bmc $g 1255319 $s 992753

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2016 $b 101 $c 8 $d 959-67 $e 20160519 $i 1592-8721 $m Haematologica $n Haematologica $x MED00001963

LZP    __

$a Pubmed-20171025